Semaglutide has emerged as a promising treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to release more insulin and curbing glucagon https://elainesfal465941.ssnblog.com/34700018/grasping-semaglutide-a-comprehensive-guide